1366050-48-7

Basic information

• Product Name: 2,8-dichloro-7-nitro-1,5-naphthyridine
• Synonyms: 2,8-dichloro-7-nitro-1,5-naphthyridine
• CAS NO: 1366050-48-7
• Molecular Formula: C₈H₃Cl₂N₃O₂
• Molecular Weight: 244.03432
• Mol File: 1366050-48-7.mol

Chemical Properties

• Boiling Point: 364.6±37.0 °C(Predicted)
• Appearance: /
• Density: 1.674±0.06 g/cm3(Predicted)
• PKA: -2.80±0.10(Predicted)
• CAS DataBase Reference: 2,8-dichloro-7-nitro-1,5-naphthyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 2,8-dichloro-7-nitro-1,5-naphthyridine(1366050-48-7)
• EPA Substance Registry System: 2,8-dichloro-7-nitro-1,5-naphthyridine(1366050-48-7)

Safety Data

• Hazardous Substances Data: 1366050-48-7(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
2,8-dichloro-7-nitro-1,5-naphthyridine is used as a synthetic intermediate for the production of pharmaceuticals. Its potent antimicrobial and antifungal properties make it a valuable component in the development of antibacterial and antifungal medications.
Used in Organic Synthesis:
2,8-dichloro-7-nitro-1,5-naphthyridine is used as a versatile building block in organic synthesis. Its unique chemical structure and reactivity allow for the creation of diverse molecular structures with potential pharmacological applications.
It is important to handle 2,8-dichloro-7-nitro-1,5-naphthyridine with caution, as it may pose certain risks to human health and the environment if not used properly.

Upstream product

• 5350-93-6 6-Chloro-pyridin-3-ylamine 
• 1354290-11-1 5-((6-chloropyridine-3-yl)-aminomethylene)-2,2-dimethyl-1,3-dioxane-4,6-dione 
• 1312760-59-0 6-chloro-1,5-naphthyridin-4-ol 
• 1366050-42-1 6-chloro-3-nitro-1,5-naphthyridin-4-ol 

Relevant articles and documents

KETONE DERIVATIVES OF IMIDAZOLES, PHARMACEUTICAL COMBINATIONS AND USES THEREOF

This application relates to ketone compounds of imidazoles, pharmaceutically acceptable salts, solvents, polymorphs or prodrugs thereof, and further relates to pharmaceutical combinations comprising the foregoing substances and uses for preventing and treating protein kinase related diseases such as cancer, metabolic diseases, and cardiovascular diseases.

Imidazole derivatives, its pharmaceutical composition and use thereof

Imidazolone compounds, pharmaceutically acceptable salts, solvates, polymorphs or prodrugs thereof are disclosed. Pharmaceutical compositions comprising above substances and uses for preventing and treating protein kinases related diseases, such as cancers, metabolic diseases, cardiovascular diseases and the like, are also disclosed.

FUSED HETEROARYLS AND THEIR USES

Provided are certain fused heteroaryls, compositions thereof and methods of use therefor.

FUSED HETEROARYLS AND THEIR USES

Provided are certain fused heteroaryls, compositions thereof and methods of use therefor.